Oncimmune Holdings full year results and conference call

DirectorsTalk Interviews

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, states that it will be announcing its full year results for the year ended 31st May 2020 on Friday, 30 October 2020.

Adam Hill, Chief Executive Officer, together with Matthew Hall, Chief Financial Officer, will host a presentation and conference call for analysts at 11:30am GMT on the day of the results.

For conference call details please contact Alexander Davis of FTI Consulting at Alexander.Davis@fticonsulting.com or 020 3727 1000.

The management team will also host on Investor Meet Company a live presentation of the results on Friday, 30 October at 15:00 GMT.

• The online presentation will be open to all existing shareholders and potential new investors.

• Questions can be submitted before the event via your Investor Meet Company dashboard or at any time during the live presentation via the “Ask a Question” function. Responses to the Q&A will be published at the earliest opportunity on the Investor Meet Company platform.

• Investor feedback can also be submitted directly to management immediately following the event.

Access to Investor Meet Company is free and interested parties can register to attend the presentation via the following link: https://www.investormeetcompany.com/essensys-plc/register-investor

Attendees who have already registered on the Investor Meet Company platform to meet the Oncimmune Holdings will automatically receive an invitation to the presentation.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

    Sintana Energy provides MI 61-101 disclosure on Challenger acquisition

    Sintana Energy Inc. has provided additional disclosure regarding the application of Multilateral Instrument 61-101 in connection with its completed acquisition of Challenger Energy Group plc by way of scheme of arrangement effective December 16, 2025.

    Avingtrans appoints Stuart Gall as CEO of Medical and Industrial Imaging division

    Avingtrans plc has announced that Stuart Gall officially assumed the role of Chief Executive Officer of its medical and industrial imaging division on 1 January 2026.

    Quadrise extends exclusive MSAR® and bioMSAR™ collaboration with Nouryon

    Quadrise plc has renewed its Exclusive Global Collaboration and Emulsifiers Sales Agreement with Nouryon, extending the partnership until 31 October 2026.

    Dekel Agri-Vision delivers improved cashew performance and higher palm oil revenues in FY25

    Dekel Agri-Vision reports a resilient FY 2025, with palm oil revenues rising approximately 5% year-on-year on stronger CPO and PKO prices, and a substantial recovery in cashew production, sales volumes, and pricing following major processing upgrades.

    Ed Loye named CEO of Great Western Mining Corporation

    Great Western Mining Corporation PLC announces the appointment of Edward (“Ed”) Loye as Chief Executive Officer from 1 February 2026.

    Elemental Royalty grants equity incentive awards

    Elemental Royalty Corporation announced the grant of stock options, restricted share units, and deferred share units under its equity incentive plan to certain officers, directors, employees, and consultants.

      Search

      Search